These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33007298)

  • 41. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
    Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP
    Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
    Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
    Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
    Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
    BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
    Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA methylation association with stage progression of head and neck squamous cell carcinoma.
    Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A
    Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
    Zuo S; Chen Y; Xu L; Tang Q; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma.
    Selvakumar P; Owens TA; David JM; Petrelli NJ; Christensen BC; Lakshmikuttyamma A; Rajasekaran AK
    Epigenetics; 2014 Apr; 9(4):579-86. PubMed ID: 24452105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic silencing of
    Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
    Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
    Puri SK; Si L; Fan CY; Hanna E
    Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study.
    Laprise C; Madathil SA; Schlecht NF; Castonguay G; Soulières D; Nguyen-Tan PF; Allison P; Coutlée F; Hier M; Rousseau MC; Franco EL; Nicolau B
    Oral Oncol; 2017 Jun; 69():56-61. PubMed ID: 28559021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
    Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
    Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa.
    Milutin Gašperov N; Sabol I; Božinović K; Dediol E; Mravak-Stipetić M; Licastro D; Dal Monego S; Grce M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
    Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
    Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.